Dr. Tod Mikuriya, one of the world’s foremost authorities on the uses of medical Cannabis. He has few peers in his clinical knowledge of Cannabis’ therapeutic uses, efficacy, history, culture, policies, routes of administration and potential for abuse.
Informal studies have shown that more than two thirds of the population experience aphrodisiac effects when using Cannabis.
This stability is known as homeostasis, which endocannabinoids promote at the most basic levels. These endocannabinoids regulate homeostasis through a wide variety of mechanisms
The endocannabinoid anandamide has been reported to affect breast cancer growth at multiple levels, by inhibiting proliferation, migration and invasiveness in vitro and in vivo and by directly inhibiting angiogenesis.
Human breast milk naturally contains many of the same cannabinoids found in marijuana, which are actually extremely vital for proper human development.
Endocannabinoids have been detected in maternal milk and activation of CB1 (cannabinoid receptor type 1) receptors appears to be critical for milk sucking and activating oral-motor musculature.
“Harm reduction” is a treatment approach that seeks to minimize the occurrence of drug/alcohol addiction and its impacts on the addict/alcoholic and society at large.
Over 600 peer reviewed articles show that numerous cancer types (lung, breast, prostate, glioma, thyroid, leukemia, lymphoma, basil cell carcinoma, melanoma, etc) are killed by cannabinoids
